Dr. Rick Doblin on MAPS’ Roadmap to Approving Psychedelics as Medicines
Dr. Richard Louis Miller interviews Dr. Rick Doblin, Historic Founder, and Executive Director, of MAPS: The Multidisciplinary Association for Psychedelic Studies, now celebrating its 25th year as the world ‘s foremost pharmaceutical organization specializing in psychedelic medicine research.

